SUBSCRIBE
SUBSCRIBE
News   Business

Evotec AG Partners With Haplogen to Develop Drugs for Infectious Diseases

November 15, 2012 | 
1 min read

HAMBURG, Germany and VIENNA, Austria, Nov. 15, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) and Haplogen GmbH have signed a collaboration agreement to discover and develop small molecules against viral infectious diseases.

Alliances Europe
MORE ON THIS TOPIC
Close up of the Federal Reserve building with the eagle statue.
Deals
After Fed Rate Cut, Biotech Stocks Face ‘Anticlimactic’ Reality
September 19, 2024
 · 
3 min read
 · 
Annalee Armstrong
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoffs
Biopharma Layoff Tracker 2024: AGC Biologics, Oncternal, Biosense Webster and More Cut Staff
September 19, 2024
 · 
152 min read
 · 
BioSpace Editorial Staff
Handshake gesture contemporary collage art. Celebrating success, congratulating for financial and business partnership, job contract deal, mutual friendship and respect. Abstract illustration isolated.
M&A
Roivant Deals Again, Sending Dermavant to Organon in Sale Worth Up to $1.2B
September 18, 2024
 · 
3 min read
 · 
Annalee Armstrong
Podcast
Sickle Cell Gene Therapies Reach Patients, Moderna Cuts, Obesity Pill Race and ESMO 2024
September 18, 2024
 · 
1 min read
 · 
Heather McKenzie